Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
31.76B | 32.92B | -26.79B | 32.99B | 30.56B | Gross Profit |
31.76B | 33.95B | 16.20B | 32.99B | 31.08B | EBIT |
997.00M | 1.44B | 16.18B | 556.00M | 2.88B | EBITDA |
1.58B | 2.43B | -887.00M | 1.33B | 2.61B | Net Income Common Stockholders |
683.00M | 1.08B | -1.07B | 416.00M | 2.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
23.48B | 17.27B | 22.50B | 12.48B | 16.90B | Total Assets |
353.88B | 328.84B | 302.26B | 343.44B | 466.52B | Total Debt |
6.89B | 7.37B | 8.57B | 8.42B | 11.13B | Net Debt |
-16.59B | -9.91B | -13.94B | -4.06B | -5.78B | Total Liabilities |
345.26B | 319.24B | 289.86B | 323.99B | 445.96B | Stockholders Equity |
8.30B | 8.79B | 12.09B | 19.20B | 19.55B |
Cash Flow | Free Cash Flow | |||
8.27B | -3.08B | 3.85B | 3.19B | 8.91B | Operating Cash Flow |
8.45B | -2.73B | 3.95B | 3.30B | 9.05B | Investing Cash Flow |
162.00M | -350.00M | 11.13B | -6.58B | -12.70B | Financing Cash Flow |
-2.49B | -1.82B | -5.47B | -3.91B | -339.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £16.58B | 26.42 | 5.48% | 7.64% | -1.13% | -38.11% | |
79 Outperform | £10.51B | 15.84 | 56.17% | 8.28% | 34.86% | 95.18% | |
70 Outperform | £23.02B | 13.58 | 12.68% | 2.74% | -17.12% | 30.62% | |
67 Neutral | $16.17B | 10.98 | 9.72% | 4.07% | 11.95% | -10.49% | |
66 Neutral | £6.56B | ― | -60.34% | 8.32% | -6.33% | ― | |
65 Neutral | £4.00B | 27.39 | 5.97% | 3.25% | 26.11% | -29.43% | |
63 Neutral | £14.50B | 88.06 | 4.06% | 9.01% | -21.56% | -61.14% |